A Double-blind, placebo-controlled randomized trial in Melbourne, Australia, entitled The Baby Biotics Trial, aims to see if supplementation of the probiotic Lactobacillus reuteri DSM 179838 is effective in reducing crying in infants less than 3 months old with infant colic when compared to placebo. Infant colic, characterized by excessive crying/fussing for no apparent cause, affects up to 20% of infants under three months of age. The trial aims to prove probiotics as an effective, practical and acceptable intervention for infant colic.
For further information: http://www.biomedcentral.com/1471-2431/12/135/abstract